from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2697c/dut

LFCtreatmentdescriptionclass of inhibitor

0.728

Amikacinug/mL Amikacintranslation

-0.170

Cap5-10ug/mL Capreomycintranslation

-0.141

Rox10-50 ug/mL Roxithromycintranslation

0.169

SM2-5 ug/mL Streptomycintranslation

1.128

Tet5-10 ug/mL Tetracyclinetranslation

-1.586

Rif0.2-5ug/mL Rifampicintranscription

-0.020

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.911

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.115

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.877

CPZ10-50 ug/mL Chlorpromazinerespiration

1.167

Clofazimine10-13 ug/mL Clofaziminerespiration

0.373

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.511

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.880

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.889

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.053

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.952

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.024

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.512

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.061

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.194

KCN5-20 ug/mL Potassium cyaniderespiration

0.072

NaN30.2-2 mM Sodium aziderespiration

-0.859

Nigericin50 uM Nigericinrespiration

-0.715

TRC10-150 ug/mL Triclosanrespiration

0.738

TRZ10-25 ug/mL Thioridazinerespiration

1.439

Valinomycin0.5-10 uM Valinomycinrespiration

-0.523

ZnSO42 mM ZnSO4respiration

-0.225

menadione6-10 ug/mL Menadionerespiration

1.134

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.290

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.551

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.059

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.977

NRP_1Non-replicating persistence stage 1dosRassociated

0.005

Amp0.2mg/mL AmpicillincellWall

0.401

Cephalexin20-100 ug/mL CephalexincellWall

0.585

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.437

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.226

EMB10-20 ug/mL EthambutolcellWall

0.838

Eta12-40 ug/mL EthionamidecellWall

1.936

INH0.2-0.4 ug/mL IsoniazidcellWall

0.471

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.783

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.349

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.476

BZA0.12 mg/mL BenzamidearomaticAmides

-0.274

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.300

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.675

H2O24 mM hydrogen peroxideDNAdamaging

-0.259

Levo10 ug/mL LevofloxacinDNAdamaging

-0.486

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.377

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.649

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.168

UVUV-irradiationDNAdamaging

0.842

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.341

Antimycin12.5-50 ug/mL Antimycin A?

0.070

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.272

PA_110-50 ug/mL Antitubercular compound PA-1?

0.239

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.700

PA8240.2-2 ug/mL PA-824?

0.570

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.685

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.004

Verapamil50 uM Verapamil?

0.300

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.322

methoxatin10-20 ug/mL Methoxatin?